本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syros Pharmaceuticals, Inc.

0.0255
+0.00052.00%
成交量:6.19万
成交额:1,643.43
市值:68.42万
市盈率:-0.01
高:0.0295
开:0.0250
低:0.0250
收:0.0250
数据加载中...
2022/09/15

重要事件披露

8-K - Current report
2022/09/15

企业合并公告

425 - Prospectuses and communications, business combinations
2022/09/02

重要事件披露

8-K - Current report
2022/09/02

企业合并公告

425 - Prospectuses and communications, business combinations
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/07/13

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/13

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/06

重要事件披露

8-K - Current report
2022/07/06

企业合并公告

425 - Prospectuses and communications, business combinations
2022/07/05

重要事件披露

8-K - Current report
2022/07/05

企业合并公告

425 - Prospectuses and communications, business combinations
2022/06/07

重要事件披露

8-K - Current report
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals